We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
-1.93%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$1.19B
AUM Growth
-$238M
(-17%)
Cap. Flow
-$297M
Cap. Flow
% of AUM
-24.99%
Top 10 Holdings %
Top 10 Hldgs %
34.47%
Holding
113
New
25
Increased
16
Reduced
22
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$37.3M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$28.9M |
| 3 |
lululemon athletica
LULU
|
+$28M |
| 4 |
Amazon
AMZN
|
+$27.8M |
| 5 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$26.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OLPX
Olaplex Holdings
OLPX
|
+$32M |
| 2 |
Roblox
RBLX
|
+$28.6M |
| 3 |
DCBO
Docebo
DCBO
|
+$22.3M |
| 4 |
AZEK
The AZEK Co
AZEK
|
+$21.3M |
| 5 |
TaskUs
TASK
|
+$21.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.36% |
| 2 | Healthcare | 20.63% |
| 3 | Consumer Discretionary | 10.23% |
| 4 | Industrials | 6.29% |
| 5 | Communication Services | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
BILL Holdings
BILL
$4.78B
| $20.9M | 1.76% |
92,000
+23,000
| +33% | +$4.8M |
|
27
Martin Marietta Materials
MLM
$33B
| $20.4M | 1.72% |
53,000
-1,100
| -2% | -$426K |
|
28
MongoDB
MDB
$32.1B
| $19.1M | 1.61% |
43,000
-1,000
| -2% | -$391K |
|
|
SWAV
29
CALL
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $18.7M | 1.57% |
+900
| New | +$148K |
|
30
Coty
COTY
$2.48B
| $18.1M | 1.52% |
2,009,605
+275,100
| +16% | +$2.45M |
|
31
Globant
GLOB
$1.61B
| $15.7M | 1.32% |
60,000
+9,000
| +18% | +$2.28M |
|
32
CrowdStrike
CRWD
$218B
| $15.6M | 1.31% |
+274,000
| New | +$12.8M |
|
33
Impinj
PI
$5.6B
| $15.5M | 1.31% |
244,000
+42,520
| +21% | +$3.07M |
|
34
Repligen
RGEN
$9.25B
| $15.2M | 1.28% |
81,000
| – | – |
|
35
Centene
CNC
$32.5B
| $14.8M | 1.25% |
175,700
+146,700
| +506% | +$12M |
|
36
Enovix
ENVX
$1.03B
| $14.4M | 1.21% |
1,150,125
-14,857
| -1% | -$208K |
|
37
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $13.5M | 1.14% |
+1,500
| New | +$139K |
|
|
ITCI
38
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $12.8M | 1.08% |
+210,000
| New | +$10.9M |
|
39
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $12.3M | 1.04% |
+1,500
| New | +$125K |
|
40
CF Industries
CF
$17.3B
| $10.7M | 0.9% |
104,000
+5,000
| +5% | +$404K |
|
41
Zai Lab
ZLAB
$2.62B
| $10.3M | 0.87% |
235,000
-38,000
| -14% | -$1.84M |
|
42
The Mosaic Company
MOS
$7.33B
| $10M | 0.85% |
+151,000
| New | +$7.55M |
|
43
Tandem Diabetes Care
TNDM
$1.56B
| $9.77M | 0.82% |
+84,000
| New | +$9.81M |
|
44
Apollo Global Management
APO
$73.4B
| $9.48M | 0.8% |
+153,000
| New | +$10.1M |
|
|
KRTX
45
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $9.13M | 0.77% |
72,000
-3,000
| -4% | -$338K |
|
46
Check Point Software Technologies
CHKP
$13.1B
| $8.92M | 0.75% |
+64,500
| New | +$8.42M |
|
47
argenx
ARGX
$54.1B
| $8.8M | 0.74% |
27,900
-11,000
| -28% | -$3.2M |
|
48
United Therapeutics
UTHR
$23.1B
| $8.79M | 0.74% |
+49,000
| New | +$9.33M |
|
49
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $8.62M | 0.73% |
308,665
| – | – |
|
50
Fortinet
FTNT
$117B
| $7.86M | 0.66% |
115,000
-45,000
| -28% | -$2.8M |
|
Similar funds
AGA
ACM
LSA
GWA
HP
SC
IAM
VCM
Atika Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Atika Capital Management held 113 positions worth $1.19B, down 17% from $1.43B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Atika Capital Management withdrew a net $297M in Q1 2022, closing 43 positions and reducing 22 holdings. Its most notable exit was Olaplex Holdings, an estimated $32M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Atika Capital Management opened a new position in Jazz Pharmaceuticals worth $31M.
- Atika Capital Management's largest Q1 2022 buy was Jazz Pharmaceuticals: 199,000 shares worth $31M.
- Atika Capital Management added most to Palo Alto Networks in Q1 2022, an estimated $37.3M increase.
- Atika Capital Management's biggest Q1 2022 reduction was Upstart Holdings, cutting an estimated $13.2M.
- Atika Capital Management fully exited Olaplex Holdings in Q1 2022, selling an estimated $32M.
- Atika Capital Management's ten largest holdings make up 34% of its $1.19B portfolio in Q1 2022.
- Atika Capital Management opened 25 new positions and closed 43 in Q1 2022.
- Atika Capital Management's portfolio value fell 17% quarter-over-quarter to $1.19B.
Based on Atika Capital Management's 13F filing for Q1 2022, filed 13 May 2022.